Cetuximab - IRDye800 Intraoperative Fluorescence Imaging in Esophagectomy of Esophageal Cancer

NCT04161560 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Drug Safety ; Drug Specificity

Interventions

DRUG: Cetuximab-IRDye800

Sponsor

Fifth Affiliated Hospital, Sun Yat-Sen University